|
2025
|
P/S
|
Vaccines for human use |
|
|
P/S
|
Vaccines for human use. |
|
|
P/S
|
vaccines for human use. |
|
|
P/S
|
Vaccines for human use |
|
|
P/S
|
Providing medical information via a website |
|
|
Invention
|
Epstein-barr virus vaccines.
The disclosure relates to EBV ribonucleic acid vaccines as well as ... |
|
|
Invention
|
Tolerizing antigen specific immunotherapies. Provided are amino acid and nucleic acid sequences t... |
|
|
Invention
|
Bromodomain and extra-terminal domain (bet) epigenetic reader decoy. Present disclosure provides ... |
|
|
Invention
|
High purity rna compositions and methods for preparation thereof.
The invention relates to impro... |
|
|
Invention
|
Synthetic nucleic acids and methods of using the same for improved polypeptide production. This d... |
|
|
Invention
|
Lipid nanoparticle compositions comprising sialic acid derivatives and the uses thereof. The pres... |
|
|
Invention
|
Methods of preparing lipid nanoparticles. The present disclosure provides methods of preparing li... |
|
|
Invention
|
Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the... |
|
|
Invention
|
Ionizable lipids and compositions thereof for delivery of therapeutic agents. The disclosure feat... |
|
|
Invention
|
Compositions and methods for detecting dsrna.
The present disclosure relates generally to antibo... |
|
|
Invention
|
Influenza vaccine. The invention relates to compositions and methods for the preparation, manufac... |
|
2024
|
Invention
|
Betacoronavirus mrna vaccines.
The disclosure relates to ribonucleic acid (RNA) vaccines and com... |
|
|
Invention
|
Betacorona virus mrna vaccines. The disclosure relates to ribonucleic acid (RNA) vaccines and com... |
|
|
Invention
|
Novel cas nucleases and polynucleotides encoding the same. The present disclosure provides novel ... |
|
|
Invention
|
Compounds and compositions for intracellular delivery of therapeutic agents.
The disclosure feat... |
|
|
Invention
|
Polynucleotides encoding glucose-6-phosphatase for the treatment of glycogen storage disease.
Th... |
|
|
Invention
|
Rna polymerase variants.
The present disclosure provides, in some aspects, variant RNA polymeras... |
|
|
Invention
|
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of... |
|
|
Invention
|
Concatemeric peptide epitope rnas.
The invention relates to concatemeric peptide epitope RNAs, a... |
|
|
Invention
|
Rna polymerase variants for co-transcriptional capping.
The present disclosure provides RNA poly... |
|
|
Invention
|
Human cytomegalovirus vaccine.
The disclosure relates to HCMV ribonucleic acid (RNA) vaccines, a... |
|
|
Invention
|
Nucleic acid vaccines for varicella zoster virus (vzv).
Aspects of the disclosure relate to nucl... |
|
|
Invention
|
Peg lipids and uses thereof.
The present disclosure in part provides compounds (i.e., PEG lipids... |
|
|
Invention
|
Polynucleotides containing a stabilizing tail region.
The invention features polynucleotides enc... |
|
|
Invention
|
Immunoglobulin a protease polypeptides, polynucleotides, and uses thereof. This disclosure relate... |
|
|
Invention
|
Humanized anti-cd3 binding molecules and uses thereof. Described herein are humanized anti-CD3 an... |
|
|
Invention
|
Polynucleotides encoding phenylalanine hydroxylase for the treatment of phenylketonuria. in vivoi... |
|
|
Invention
|
Delivery and formulation of engineered nucleic acids. Provided are formulations, compositions and... |
|
|
Invention
|
Delivery and formulation of engineered nucleic acids.
Provided are formulations, compositions an... |
|
|
Invention
|
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof. The present disclosure pr... |
|
|
Invention
|
Rna cancer vaccines.
The disclosure relates to cancer ribonucleic acid (RNA) vaccines, as well a... |
|
|
Invention
|
Respiratory syncytial virus vaccine.
The disclosure relates to respiratory syncytial vims (RSV) ... |
|
|
Invention
|
Messenger ribonucleic acids for enhancing immune responses and methods of use thereof.
The discl... |
|
|
Invention
|
Terminally modified rna.
The invention relates to compositions and methods for the manufacture a... |
|
2023
|
Invention
|
Ribosomal engagement potency assay.
Provided herein are methods for detecting and/or measuring m... |
|
|
Invention
|
Rna polymerase variants.
RNA polymerase variants enable high efficiency transcription of RNA. In... |
|
|
Invention
|
Detection of mrna purity in a mixture.
Provided herein are methods of detecting mRNA purity in a... |
|
|
Invention
|
Cross mixers for lipid nanoparticle production, and methods of operating the same.
The present d... |
|
|
Invention
|
Messenger ribonucleic acids with extended half-life.
The disclosure features a polynucleotide en... |
|
|
Invention
|
Polynucleotides encoding fanconi anemia, complementation group proteins for the treatment of fanc... |
|
|
Invention
|
Mrnas encoding checkpoint cancer vaccines and uses thereof.
The disclosure features lipid nanopa... |
|
|
Invention
|
Mucosal administration methods and formulations.
The present disclosure provides compositions an... |
|
|
Invention
|
Continuous precipitation for mrna purification.
Aspects of the disclosure relate to methods of p... |
|
|
Invention
|
In vitro transcription dna purification and recycling.
Provided herein are methods of preparing ... |
|
2022
|
Invention
|
Compounds and compositions for delivery of therapeutic agents.
The disclosure features novel lip... |
|
|
Invention
|
Lipid amines.
The present invention relates to lipid amine compounds of formula (A1) which are u... |
|
|
Invention
|
Drug product surrogate solutions.
Provided herein are methods and compositions of a surrogate mR... |
|
|
Invention
|
Composition of mrna-encoded il15 fusion proteins and methods of use thereof.
The present disclos... |
|
|
Invention
|
Lipid nanoparticle formulations and methods of synthesis thereof.
Stabilized formulations of lip... |
|
|
Invention
|
Extraction-less reverse phase (rp) chromatography of mrna encapsulated in lipid nanoparticles for... |
